Antares Vision, a provider of serialization-based track and trace solutions for the pharmaceutical industry, is moving its headquarters to a larger facility in Moorestown, NJ in early 2017. The space allows for increased capacity of ready-to-deploy serialization modules to help customers meet the upcoming November 27 regulatory deadline under the Drug Supply Chain Security Act, which requires pharma manufacturers to print a unique product identification code on all Rx units of sale and homogenous cases distributed domestically.
The new headquarters increases warehousing space fourfold, and includes a testing facility allowing Antares to conduct multiple simultaneous factory acceptance tests (FATs).
An adjoining demonstration showroom will display a rotating array of functioning packaging lines, including the Print & Check EVO, the P&C Advance, a top view matrix station, manual stations, and a tablet inspection machine, as well as the new Omnivision 360° Bottle Tracking System.
According to Andrew Pietrangelo, president, Antares Vision - North America: "As we start the final push toward this coming November’s initial serialization regulations here in the US, the expanded, higher-visibility new headquarters says, loudly and clearly, that the world’s leader in serialization-based track & trace solutions is here to help pharma companies meet regulation compliance deadlines."